| Identity |
| Other names | OCIM |
| Hugo | MYEOV |
| Location | 11q13 |
| Local_order | 350 kb centromeric of cyclin D1 |
| Note | detected by application of the NIH/3T3 tumorigenicity assay. However MYEOV cDNA was not positive in NIH/3T3 assay. |
| DNA/RNA |
| Description | 2 exons; 3.5 kb transcript represents unspliced mRNA. |
| Transcription | main transcript 2.8 kb (broad band because of alternative splice products); minor transcript 3.5 kb.; coding sequence 313 or 255 amino acids. In normal tissues hardly any expression detectable. High expression in a subset of multiple myeloma cell lines with a t(11;14)(q13;q32) and in breast tumors and esophageal squamous cell carcinomas with or without 11q13 amplification. |
| Protein |
| Description | 313 or 255 amino acids; contains one RNP-1 motif and 6 regions that might function as a transmembrane domain. Leucine-rich stretch at C-terminal. |
| Expression | 5Ô UTR inhibits efficient translation of the protein |
| Localisation | in endoplasmic reticulum and mitochondria. |
| Implicated in |
| Entity | t(11;14)(q13;q32) |
| Disease | subset of multiple myeloma cell lines with t(11;14)(q13;q32) |
| Cytogenetics | myeov overexpression due to juxtaposition to the 5' enhancer or the most telomeric 3' enhancer of the immunoglobulin heavy chain (IgH). |
| Entity | 11q13 amplification and/or overexpression |
| Disease | breast cancer; esophageal squamous cell carcinomas. |
| Prognosis | MYEOV DNA amplification correlated with estrogen and progesterone receptor-positive cancer, invasive lobular carcinoma type and axillary nodal involvement. In contrast to Cyclin D1 amplification, no association with disease outcome could be found. |
| External links |
| Bibliography |
| Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32). |
| Janssen JW, Vaandrager JW, Heuser T, Jauch A, Kluin PM, Geelen E, Bergsagel PL, Kuehl WM, Drexler HG, Otsuki T, Bartram CR, Schuuring E |
| Blood. 2000 ; 95 (8) : 2691-2698. |
| PMID 10753852 |
| MYEOV, a gene at 11q13, is coamplified with CCND1, but epigenetically inactivated in a subset of esophageal squamous cell carcinomas. |
| Janssen JW, Imoto I, Inoue J, Shimada Y, Ueda M, Imamura M, Bartram CR, Inazawa J |
| Journal of human genetics. 2002 ; 47 (9) : 460-464. |
| PMID 12202983 |
| MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer. |
| Janssen JW, Cuny M, Orsetti B, Rodriguez C, Vallˆ©s H, Bartram CR, Schuuring E, Theillet C |
| International journal of cancer. Journal international du cancer. 2002 ; 102 (6) : 608-614. |
| PMID 12448002 |
| REVIEW articles | automatic search in PubMed |
| Last year publications | automatic search in PubMed |
| Contributor(s) |
| Written | 12-2002 | Johannes W.G. Janssen |
| Janssen Institut für Humangenetik Universitätsklinikum Heidelberg Im Neuenheimer Feld 328 D-69120 Heidelberg, Germany |
| Citation |
| This paper should be referenced as such : |
| Janssen JWG . MYEOV. Atlas Genet Cytogenet Oncol Haematol. December 2002 . URL : http://AtlasGeneticsOncology.org/Genes/MYEOVID395.html |
| © Atlas of Genetics and Cytogenetics in Oncology and Haematology | indexed on : Wed Jul 2 08:25:18 2008 |
For comments and suggestions or contributions, please contact us